1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: NCI-85-C-62, NCI-T85-0096N, T85-0096
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: POG-8741/42, POG-8741, POG-8742
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 31
Sponsor: NCI
Protocol IDs: POG-8759
|
|
5.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1588
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: not over 30
Sponsor: NCI
Protocol IDs: CCG-7921, POG-9351, INT-0133
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: GOG-149, GOG-0149
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9313, CLB-9394, E-S9313, NCCTG-933051, INT-0137
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor:
Protocol IDs: EORTC-06931, NCT00002549
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor: Other
Protocol IDs: HOG-LUN93-2, NCI-V94-0422
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 3 to 21
Sponsor: NCI
Protocol IDs: POG-9331, CCG-9932, INT-0140
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: MDA-DM-94017, NCI-T94-0040D, NCT00002565, T94-0040
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: FRE-FNCLCC-PALSAR-93, NCI-F94-0018
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: MRC-LU09, EU-94023
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: at least 1 + under 20 at diag.
Sponsor: NCI
Protocol IDs: CCG-1941
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 30 and under
Sponsor: NCI
Protocol IDs: POG-9354, CCG-7942, INT-0154
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95088, RP-56976-TAX-320, NCI-V96-0830
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15 at initial diagnosis
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 1 and under 15
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-XI, EU-95036
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-LU20, EU-95041
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 65
Sponsor:
Protocol IDs: IBCSG-15-95, EU-96021, NCT00002784
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 65
Sponsor: Other
Protocol IDs: UNMC-35195, NCI-V96-0918
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: GER-NB90, EU-96004, NCT00002802
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: E-2493, E2493
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-1951, NCT00002816
|
